White-Matter Deficits Found in Codeine-Containing Cough Syrup Users
By HospiMedica International staff writers Posted on 01 Sep 2014 |
A magnetic resonance imaging (MRI) study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and linked these changes with increased impulsivity in codeine-containing cough syrup users. These findings were consistent with findings from earlier research of heroin and cocaine addicts. White matter disruptions also correlated with the duration of CCS use.
Researchers used MR diffusion tensor imaging (DTI), combined with fractional anisotropy, to study the white matter integrity of chronic CCS users. Deficits were discovered in multiple regions of the brain, including the inferior fronto-occipital fasciculus, which other studies have found to be abnormal in other forms of addiction, such as addiction to the Internet, alcohol, and heroin.
The researchers, from the department of medical imaging of the First Affiliated Hospital of Gannan Medical University (Ganzhou, China), and the departments of medical imaging and interventional radiology, Cancer Center, Sun Yat-Sen University (Guangzhou, China), reported that the white matter deficits in CCS users also correlated with increased impulsivity characteristics in the study subjects, as measured by the Barratt impulsiveness scale. These findings were consistent with the findings of earlier studies of heroin and cocaine addicts. White matter disruptions also correlated with the duration of CCS use.
Codeine-containing cough syrups have become one of the most widespread drugs of abuse in young people worldwide. Progressive alterations in the white matter of users' brains may cause greater impulsivity in CCS users.
The study’s findings were published August 2014 on the website of the American Journal of Neuroradiology (AJNR).
Related Links:
Gannan Medical University
Researchers used MR diffusion tensor imaging (DTI), combined with fractional anisotropy, to study the white matter integrity of chronic CCS users. Deficits were discovered in multiple regions of the brain, including the inferior fronto-occipital fasciculus, which other studies have found to be abnormal in other forms of addiction, such as addiction to the Internet, alcohol, and heroin.
The researchers, from the department of medical imaging of the First Affiliated Hospital of Gannan Medical University (Ganzhou, China), and the departments of medical imaging and interventional radiology, Cancer Center, Sun Yat-Sen University (Guangzhou, China), reported that the white matter deficits in CCS users also correlated with increased impulsivity characteristics in the study subjects, as measured by the Barratt impulsiveness scale. These findings were consistent with the findings of earlier studies of heroin and cocaine addicts. White matter disruptions also correlated with the duration of CCS use.
Codeine-containing cough syrups have become one of the most widespread drugs of abuse in young people worldwide. Progressive alterations in the white matter of users' brains may cause greater impulsivity in CCS users.
The study’s findings were published August 2014 on the website of the American Journal of Neuroradiology (AJNR).
Related Links:
Gannan Medical University
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure